Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15017 total
Movado Group heads into its fiscal Q1 2026 earnings report — due Thursday morning — having posted its best weekly gain in months, with short sellers doing little to fight the move. The stock climbed 13.1% on the week…
Motorola Solutions enters the late-May period having nearly recovered from a sharp post-earnings selloff — yet short interest has quietly moved to a six-week high, creating a mild but notable divergence from the…
Modine Manufacturing has delivered its earnings catalyst and the market has responded emphatically — a 21% weekly gain to $295.88 leaves the stock sitting above the mean analyst price target, reframing the near-term…
MU is up 28% on the week and closing in on $900 — and the analyst community is still catching up to the price. The most striking development this week is the sheer scale of target revisions. Barclays raised its target…
MSTR is down 2.9% on the week to $159.93, even as its closest crypto-equity peers post double-digit gains — and short interest has stayed stubbornly elevated, keeping a 15% float short figure that refuses to…
Microsoft ends the week with its options market stuck in an unusually defensive posture — and the data suggests this is no longer a transient spike but a feature of the current setup. The clearest signal remains in…
Mesa Laboratories heads into the post-earnings period with a sharp divergence between its cost discipline and its top-line delivery — an EPS beat so large it obscures a sales miss that investors can't ignore. The…
MGM Resorts International enters the final days of May with a fresh analyst catalyst reshaping how the Street views its Las Vegas recovery: a same-day upgrade from Truist Securities has landed just as short interest…
Bath & Body Works printed its Q1 results on May 27 and the stock has snapped back — up 10% on the week to $17.73 — but the short side has barely flinched, and the analyst community spent the days before the print…
Eli Lilly and Company enters the final days of May having added 4.2% on the week, closing at $1,064.74 — its highest level since early in the year — with a fresh analyst target raise from BofA arriving the same day to…
Lam Research has staged one of its sharpest weekly recoveries in recent memory, with the price reversal from last week's note making the prior article's cautionary tone look very dated very fast. The move is the story.…
Kennametal Inc. heads into the back half of its fiscal year with a fresh downgrade landing on the same day the stock posted its strongest weekly gain in months — a collision that captures the stock's divided setup…
JPMorgan Chase has clawed back the losses flagged in last week's note, rising 3.7% over the past five days to $306.74 — but the same executives who sold into the May weakness are still selling into the recovery. The…
Viavi Solutions has reversed course sharply, climbing back to $53.79 — nearly recapturing the exact prices at which insiders were selling just three weeks ago. The price recovery is the week's central tension. Last…
Intel enters the final days of May having added 11.5% on the week and nearly 50% over the past month, trading at $123.52 — yet the mean analyst price target remains $87.76, leaving the stock roughly 41% above…
NSIT enters the back half of May with one of the sharpest short-term reversals in its recent history — a 13% weekly gain capped by a same-day upgrade from JP Morgan, the combination putting the stock's long stretch of…
ICU Medical heads into the final days of May with a fresh analyst upgrade, a stock up 9% on the week, and short sellers caught leaning the wrong way. The week's defining moment came from the Street. Needham upgraded…
Host Hotels & Resorts enters the final days of May riding a six-week re-rating that has outpaced most of its peers — and the Street is still revising higher even as the stock nudges above several freshly-raised price…
Honeywell International exits its May 22 earnings event in notably better shape than it entered — up 6.7% on the week to $231.72, with the Street quickly revising upward. The analyst response to the print has been…
Home Depot has clawed back 2.7% on the week to $310.54, but the recovery is fragile — still down 7.5% on the month, and trading well below a consensus that spent the past week getting cut. The post-Q1 repricing by…
